Duncan-Williams

Duncan-Williams is maintaining its Buy rating on Varian Medical Systems Inc. (NYSE: VAR) and its 12-month price target of $80.00. “This represents approximately 20 times our fiscal 2012 EPS estimate of $3.85 plus approximately $4.85 in cash per share,” Duncan-Williams writes. “We are raising our...

Duncan-Williams, in its report previewing Q1:11 earnings on eReasearch Technology (NASDAQ: ERT), is maintaining both its Buy rating, as well as its price target of $8.50 on the stock. In the report, Duncan-Williams writes, “Our Q1:11 revenue and adjusted EPS estimates are $42.5 million and $0.07,...

According to Duncan-Williams, Diamond Offshore Drilling (NYSE: DO) reported first quarter earnings of $1.79 per share soundly beating the consensus estimate of $1.43 per share and its estimate of $1.52 per share on revenues of $806 million. Duncan-Williams said that Diamond incurred only 168 days...

According to Duncan-Williams, Ensco (NYSE: ESV) released a fleet status on Friday after the close. Duncan-Williams reported that the changes included increased downtime, contract slippage, and lower rates in the domestic market as the rigs wait on permits. “All of the contract changes lead our...

Duncan-Williams is out with its report today on ICU Medical (NASDAQ: ICUI), maintaining Buy. In a note to clients, Duncan-Williams writes, "On April 14, 2011, ICUI announced it was awarded a 36-month contract with Premier Purchasing Partners, L.P., the group purchasing unit of Premier Inc., for...

Duncan-Williams is out with its report today on Merit Medical Systems (NASDAQ: MMSI), maintaining Hold. In a note to clients, Duncan-Williams writes, "We are maintaining our HOLD rating on MMSI based on valuation as MMSI is trading at 21 times our 2011 adjusted EPS estimate of $1.00. This is in...

According to Duncan-Williams, DST Systems' (NYSE: DST) updated valuation framework supports its Buy Rating. Duncan-Williams reported that it continues to believe that DST shares remain undervalued trading at just 4.7x on an enterprise value/11E EBITDA basis. “In this report, we have updated our...

Duncan-Williams reported on the Prepaid industry after attending the Prepaid Expo in Orlando, FL. According to the report, "Many of the concerns and challenges that came up at the conference along with others have recently filtered into the stock prices of NetSpend (NTSP, Buy, $10.41) and Green...

Duncan-Williams reports that, with regard to Cadence Pharmaceuticals Inc. (NASDAQ: CADX), “after reviewing the 10K and speaking with management we have realized that our first year ramp curve is overly aggressive.” “Management indicated that stocking a hospital typically corresponds to a single...

Duncan-Williams is maintaining its Hold rating on shares of Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH). “We report that the FDA approved an ANDA for generic epinastine hydrochloride (Allergan's Elestat) on March 14,” Duncan-Williams writes. “The generic company receiving the first ANDA approval...

Analysts at Duncan-Williams downgrade Noble Corporation (NYSE: NE) from “hold” to “reduce.”   NE shares gained 2.96% to close at $44.92 yesterday.   <a href="http://www.benzinga.com/analyst-ratings">More Analyst Ratings here</a>

Analysts at Duncan-Williams downgrade Transocean Ltd (NYSE: RIG) from “buy” to “reduce.” RIG shares dropped 1.72% to close at $80.62 yesterday. More Analyst Ratings here

Analysts at Duncan-Williams upgrade Inspire Pharmaceuticals Inc (NASDAQ: ISPH) from “sell” to “hold.” ISPH shares gained 2.61% to close at $4.33 yesterday. More Analyst Ratings here

Analysts at Duncan-Williams upgrade Global Cash Access Holdings Inc (NYSE: GCA) from “hold” to “buy.” GCA shares fell 0.97% to close at $3.05 yesterday. More Analyst Ratings here

Duncan-Williams Inc. is out with a research report this morning, where it reiterates its Buy rating on Fidelity National Information Services Inc. (NYSE: FIS); it has a $32.00 price target on the stock. The DW analysts cited their attendance at FIS' analyst day, where they came away with a better...